Azithromycin Compared with β-Lactam Antibiotic Treatment Failures in Pneumococcal Infections of Children

Blanca E. Gonzalez, Gerardo Martinez-Aguilar, Edward Mason, Sheldon Kaplan

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Objective: To determine whether treatment failures occurred more commonly with azithromycin than with β-lactam antibiotics in children who developed invasive pneumococcal disease within 30 days of receiving prior antimicrobial therapy. Methods: Retrospective review of medical records of children evaluated at Texas Children's Hospital between 1996 and 2002 who had received antimicrobials (azithromycin or a β-lactam antibiotic) and developed invasive pneumococcal disease within 30 days. Treatment failure was defined as invasive pneumococcal infection that occurred while taking antimicrobials or within 3 days of stopping azithromycin treatment or 1 day of stopping β-lactam treatment. Penicillin and azithromycin susceptibilities were determined and categorized according to National Committee for Clinical Laboratory Standards guidelines. Results: We identified 21 and 33 children with similar demographic features who had developed invasive pneumococcal disease within 1 month of receiving azithromycin or a β-lactam antibiotic, respectively. Eleven (52%) children in the azithromycin group and 11 (33%) in the β-lactam group met the definition for treatment failures (P = 0.34). Eight treatment failures while receiving azithromycin were caused by pneumococci with the macrolide-resistant (M) phenotype, 2 with the macrolide-, lincosamide- and streptogramin B-resistant (MLSB) phenotype and 1 by a macrolide-susceptible organism. In the β-lactam group 7 had a penicillin-resistant isolate, 3 had an intermediately susceptible isolate and 1 had a susceptible isolate. Conclusions: Our study suggests that treatment failures among patients who developed invasive disease within 30 days of receiving an antimicrobial occur as frequently in patients who receive β-lactam antibiotics as in those who receive azithromycin. Furthermore macrolide resistant organisms are not more likely to be recovered after a macrolide treatment failure than a penicillin-nonsusceptible isolate being recovered after a β-lactam treatment failure (P = 1.0).

Original languageEnglish (US)
Pages (from-to)399-405
Number of pages7
JournalPediatric Infectious Disease Journal
Volume23
Issue number5
DOIs
StatePublished - May 1 2004

Keywords

  • Macrolides
  • Streptococcus pneumoniae
  • Treatment failures

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Azithromycin Compared with β-Lactam Antibiotic Treatment Failures in Pneumococcal Infections of Children'. Together they form a unique fingerprint.

Cite this